Pfizer’s ESSA Pharma EPIX Stock Holding History

Pfizer’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,675,000	Closed	-$320K	–	20
2025 Q3	$320K	Hold	1,675,000	–	–	0.07%	18
2025 Q2	$2.85M	Hold	1,675,000	–	–	0.49%	14
2025 Q1	$2.65M	Hold	1,675,000	–	–	0.53%	13
2024 Q4	$3M	Buy	+1,675,000	New	+$5.33M	0.12%	15

Pfizer's EPIX Position: Q4 2025 in Review

Pfizer sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 1,675,000 shares — an estimated $320K sold.

Pfizer first reported a position in EPIX in Q4 2024 and held it in 4 quarters. The position peaked at $3M in Q4 2024. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.

Pfizer reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
Pfizer sold 1,675,000 ESSA Pharma shares in Q4 2025, an estimated $320K.
Pfizer first reported a position in ESSA Pharma in Q4 2024 and held it in 4 quarters.
Pfizer's ESSA Pharma position peaked at $3M in Q4 2024.
0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.

Based on Pfizer's 13F filing for Q4 2025, filed 12 Feb 2026.